An International, Multicentre, Prospective, Single-Arm Study to Assess the Effect on Voluntary Movements of AbobotulinumtoxinA 1500 U Administered in Both Upper and Lower Limbs in Conjunction With a Guided Self-Rehabilitation Contract in Adult Subjects With Spastic Hemiparesis
Phase of Trial: Phase IV
Latest Information Update: 12 Oct 2017
At a glance
- Drugs Botulinum toxin A (Primary)
- Indications Paresis
- Focus Therapeutic Use
- Acronyms ENGAGE
- Sponsors Ipsen
- 12 Oct 2017 According to an Ipsen media release, methodology of this study will be presented at at the annual assembly of the American Academy of Physical Medicine and Rehabilitation (AAPM&R) 2017.
- 30 Jan 2017 Status changed from not yet recruiting to recruiting.
- 24 Nov 2016 New trial record